| # | Side effect | Count |
|---|---|---|
| 0 | CYTOKINE RELEASE SYNDROME | 855 |
| 1 | DISEASE PROGRESSION | 486 |
| 2 | OFF LABEL USE | 325 |
| 3 | DEATH | 304 |
| 4 | PYREXIA | 221 |
| 5 | NEUTROPENIA | 198 |
| 6 | IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME | 156 |
| 7 | COVID-19 | 126 |
| 8 | ANAEMIA | 115 |
| 9 | INFECTION | 114 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | HIGH GRADE B-CELL LYMPHOMA BURKITT-LIKE LYMPHOMA REFRACTORY | 4 | 0.8000 |
| 1 | HERPETIC RADICULOPATHY | 1 | 0.1250 |
| 2 | PRIMARY CARDIAC LYMPHOMA | 2 | 0.1250 |
| 3 | BLOOD TYPE INCOMPATIBILITY | 1 | 0.1250 |
| 4 | HEPATOBILIARY NEOPLASM | 1 | 0.1000 |
| 5 | EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) STAGE IV | 1 | 0.0833 |
| 6 | TUMOUR FLARE | 56 | 0.0820 |
| 7 | CD19 ANTIGEN LOSS | 1 | 0.0625 |
| 8 | INTERSTITIAL LUNG THICKENING | 1 | 0.0625 |
| 9 | FACTOR XI DEFICIENCY | 1 | 0.0500 |